NIH | National Cancer Institute | NCI Wiki  
Long NameStaging, Corpus Uteri Sarcoma NCI Standard Template
DefinitionThe collection of CDEs used in the corpus uteri sarcoma staging module based on AJCC Edition 7 and FIGO 2009 standards. This includes Leiomyosarcoma, Endometrial Stromal Sarcoma and Adenosarcoma.
ContextcaBIG
Protocol Long NameNCI Standard Template Forms
WorkflowRELEASED
TypeCRF
Public ID3446968
Version1.0
Module Long NameModule InstructionsQuestionCDECDE Public IDCDE VersionQuestion InstructionsValue Domain Data TypeValue Domain Unit of MeasureDisplay FormatValid ValueForm Value Meaning TextForm Value Meaning Desc.
Mandatory Corpus Uteri Sarcoma Staging QuestionsThese items must be included when this data is collected for reporting.
Date Current Staging Assessment CompletedCurrent Stage Complete Assessment Date627393.0DATEMM/DD/YYYY
Conditional Leiomyosarcoma, Endometrial Stromal Sarcoma Staging QuestionsThere are business rules to indicate situations under which this element should be used on a case report form.
Clinical T StageLeiomyosarcoma and Endometrial Stromal Sarcoma American Joint Committee on Cancer (AJCC) Edition 7 Clinical Tumor T Stage34467891.0Conditionality Rule: Inclusion based on patient population being studied.CHARACTER
TXLeiomyosarcoma and Endometrial Stromal Sarcoma pTX TNM Finding v7Primary tumor cannot be assessed. (from AJCC 7th Ed.)
T0Leiomyosarcoma and Endometrial Stromal Sarcoma pT0 TNM Finding v7No evidence of primary tumor. (from AJCC 7th Ed.)
T1Leiomyosarcoma and Endometrial Stromal Sarcoma pT1 TNM Finding v7Tumor limited to the uterus. (from AJCC 7th Ed.)
T1aLeiomyosarcoma and Endometrial Stromal Sarcoma pT1a TNM Finding v7Tumor 5 cm or less in greatest dimension. (from AJCC 7th Ed.)
T1bLeiomyosarcoma and Endometrial Stromal Sarcoma pT1b TNM Finding v7Tumor more than 5 cm in greatest dimension. (from AJCC 7th Ed.)
T2Leiomyosarcoma and Endometrial Stromal Sarcoma pT2 TNM Finding v7Tumor extends beyond the uterus, within the pelvis. (from AJCC 7th Ed.)
T2aLeiomyosarcoma and Endometrial Stromal Sarcoma pT2a TNM Finding v7Tumor involves adnexa. (from AJCC 7th Ed.)
T2bLeiomyosarcoma and Endometrial Stromal Sarcoma pT2b TNM Finding v7Tumor involves other pelvic tissues. (from AJCC 7th Ed.)
T3Leiomyosarcoma and Endometrial Stromal Sarcoma pT3 TNM Finding v7Tumor infiltrates abdominal tissues. (from AJCC 7th Ed.)
T3aLeiomyosarcoma and Endometrial Stromal Sarcoma pT3a TNM Finding v7Tumor infiltrates abdominal tissues, one site. (from AJCC 7th Ed.)
T3bLeiomyosarcoma and Endometrial Stromal Sarcoma pT3b TNM Finding v7Tumor infiltrates abdominal tissues, more than one site. (from AJCC 7th Ed.)
T4Leiomyosarcoma and Endometrial Stromal Sarcoma pT4 TNM Finding v7Tumor invades bladder or rectum. (from AJCC 7th Ed.)
Clinical N StageLeiomyosarcoma and Endometrial Stromal Sarcoma American Joint Committee on Cancer (AJCC) Edition 7 Clinical Regional Lymph Node N Stage34469511.0Conditionality Rule: Inclusion based on patient population being studied.CHARACTER
NXLeiomyosarcoma and Endometrial Stromal Sarcoma pNX TNM Finding v7Regional lymph nodes cannot be assessed. (from AJCC 7th Ed.)
N0Leiomyosarcoma and Endometrial Stromal Sarcoma pN0 TNM Finding v7No regional lymph node metastasis. (from AJCC 7th Ed.)
N1Leiomyosarcoma and Endometrial Stromal Sarcoma pN1 TNM Finding v7Regional lymph node metastasis. (from AJCC 7th Ed.)
Clinical M StageLeiomyosarcoma and Endometrial Stromal Sarcoma American Joint Committee on Cancer (AJCC) Edition 7 Clinical Distant Metastasis M Stage34469531.0Conditionality Rule: Inclusion based on patient population being studied.CHARACTER
M0Leiomyosarcoma and Endometrial Stromal Sarcoma cM0 TNM Finding v7No distant metastasis. (from AJCC 7th Ed.)
M1Leiomyosarcoma and Endometrial Stromal Sarcoma cM1 TNM Finding v7Distant metastasis (excluding adnexa, pelvic and abdominal tissues). (from AJCC 7th Ed.)
Pathologic T StageLeiomyosarcoma and Endometrial Stromal Sarcoma American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Tumor T Stage34467901.0Conditionality Rule: Inclusion based on patient population being studied.CHARACTER
TXLeiomyosarcoma and Endometrial Stromal Sarcoma pTX TNM Finding v7Primary tumor cannot be assessed. (from AJCC 7th Ed.)
T0Leiomyosarcoma and Endometrial Stromal Sarcoma pT0 TNM Finding v7No evidence of primary tumor. (from AJCC 7th Ed.)
T1Leiomyosarcoma and Endometrial Stromal Sarcoma pT1 TNM Finding v7Tumor limited to the uterus. (from AJCC 7th Ed.)
T1aLeiomyosarcoma and Endometrial Stromal Sarcoma pT1a TNM Finding v7Tumor 5 cm or less in greatest dimension. (from AJCC 7th Ed.)
T1bLeiomyosarcoma and Endometrial Stromal Sarcoma pT1b TNM Finding v7Tumor more than 5 cm in greatest dimension. (from AJCC 7th Ed.)
T2Leiomyosarcoma and Endometrial Stromal Sarcoma pT2 TNM Finding v7Tumor extends beyond the uterus, within the pelvis. (from AJCC 7th Ed.)
T2aLeiomyosarcoma and Endometrial Stromal Sarcoma pT2a TNM Finding v7Tumor involves adnexa. (from AJCC 7th Ed.)
T2bLeiomyosarcoma and Endometrial Stromal Sarcoma pT2b TNM Finding v7Tumor involves other pelvic tissues. (from AJCC 7th Ed.)
T3Leiomyosarcoma and Endometrial Stromal Sarcoma pT3 TNM Finding v7Tumor infiltrates abdominal tissues. (from AJCC 7th Ed.)
T3aLeiomyosarcoma and Endometrial Stromal Sarcoma pT3a TNM Finding v7Tumor infiltrates abdominal tissues, one site. (from AJCC 7th Ed.)
T3bLeiomyosarcoma and Endometrial Stromal Sarcoma pT3b TNM Finding v7Tumor infiltrates abdominal tissues, more than one site. (from AJCC 7th Ed.)
T4Leiomyosarcoma and Endometrial Stromal Sarcoma pT4 TNM Finding v7Tumor invades bladder or rectum. (from AJCC 7th Ed.)
Pathologic N StageLeiomyosarcoma and Endometrial Stromal Sarcoma American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Regional Lymph Node N Stage34469521.0Conditionality Rule: Inclusion based on patient population being studied.CHARACTER
NXLeiomyosarcoma and Endometrial Stromal Sarcoma pNX TNM Finding v7Regional lymph nodes cannot be assessed. (from AJCC 7th Ed.)
N0Leiomyosarcoma and Endometrial Stromal Sarcoma pN0 TNM Finding v7No regional lymph node metastasis. (from AJCC 7th Ed.)
N1Leiomyosarcoma and Endometrial Stromal Sarcoma pN1 TNM Finding v7Regional lymph node metastasis. (from AJCC 7th Ed.)
Pathologic M StageLeiomyosarcoma and Endometrial Stromal Sarcoma American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Distant Metastasis M Stage34469541.0Conditionality Rule: Inclusion based on patient population being studied.CHARACTER
M1Leiomyosarcoma and Endometrial Stromal Sarcoma pM1 TNM Finding v7Distant metastasis (excluding adnexa, pelvic and abdominal tissues). (from AJCC 7th Ed.)
Disease StageLeiomyosarcoma and Endometrial Stromal Sarcoma American Joint Committee on Cancer (AJCC) Edition 7 Group Stage34469671.0Conditionality Rule: Inclusion based on patient population being studied.CHARACTER
IStage I Uterine SarcomaStage I includes: T1, N0, M0. T1: Tumor limited to the uterus. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)
IAStage IA Uterine SarcomaStage IA includes: T1a, N0, M0. T1a: For leiomyosarcoma and endometrial stromal sarcoma: tumor 5 cm or less in greatest dimension. For adenosarcoma: tumor limited to endometrium/endocervix. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)
IBStage IB Uterine SarcomaStage IB includes: T1b, N0, M0. T1b: For leiomyosarcoma and endometrial stromal sarcoma: tumor more than 5 cm in greatest dimension. For adenosarcoma: tumor invades to less than half of the myometrium. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)
IIStage II Uterine SarcomaStage II includes: T2, N0, M0. T2: Tumor extends beyond the uterus, within the pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)
IIIAStage IIIA Uterine SarcomaStage IIIA includes: T3a, N0, M0. T3a: Tumor infiltrates abdominal tissues, one side. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)
IIIBStage IIIB Uterine SarcomaStage IIIB includes: T3b, N0, M0. T3b: Tumor infiltrates abdominal tissues, more than one side. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)
IIICStage IIIC Uterine SarcomaStage IIIC includes: T1-T3, N1, M0. T1: Tumor limited to the uterus. T2: Tumor extends beyond the uterus, within the pelvis. T3: Tumor infiltrates abdominal tissues. N1: Regional lymph node metastasis. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)
IVAStage IVA Uterine SarcomaStage IVA includes: T4, Any N, M0. T4: Tumor involves bladder or rectum. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)
IVBStage IVB Uterine SarcomaStage IVB includes: Any T, Any N, M1. M1: Distal metastasis (excluding adnexa, pelvic and abdominal tissues). This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)
Stage unknownStage UnknownA finding indicating that the extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.
Conditional Adenosarcoma Staging QuestionsThere are business rules to indicate situations under which this element should be used on a case report form. The disease stage element is intended to be used as a generic element to capture staging data when disease specific data is not required.
Clinical T StageUterine Adenosarcoma American Joint Committee on Cancer (AJCC) Edition 7 Clinical Tumor T Stage34473041.0CHARACTER
TXAdenosarcoma pTX TNM Finding v7Primary tumor cannot be assessed. (from AJCC 7th Ed.)
T0Adenosarcoma pT0 TNM Finding v7No evidence of primary tumor. (from AJCC 7th Ed.)
T1Adenosarcoma pT1 TNM Finding v7Tumor limited to the uterus. (from AJCC 7th Ed.)
T1aAdenosarcoma pT1a TNM Finding v7Tumor limited to endometrium/endocervix. (from AJCC 7th Ed.)
T1bAdenosarcoma pT1b TNM Finding v7Tumor invades to less than half of the myometrium. (from AJCC 7th Ed.)
T1cAdenosarcoma pT1c TNM Finding v7Tumor invades more than half of the myometrium. (from AJCC 7th Ed.)
T2Adenosarcoma pT2 TNM Finding v7Tumor extends beyond the uterus, within the pelvis. (from AJCC 7th Ed.)
T2aAdenosarcoma pT2a TNM Finding v7Tumor involves adnexa. (from AJCC 7th Ed.)
T2bAdenosarcoma pT2b TNM Finding v7Tumor involves other pelvic tissues. (from AJCC 7th Ed.)
T3Adenosarcoma pT3 TNM Finding v7Tumor involves abdominal tissues. (from AJCC 7th Ed.)
T3aAdenosarcoma pT3a TNM Finding v7Tumor involves abdominal tissues, one site. (from AJCC 7th Ed.)
T3bAdenosarcoma pT3b TNM Finding v7Tumor invades abdominal tissues, more than one site. (from AJCC 7th Ed.)
T4Adenosarcoma pT4 TNM Finding v7Tumor invades bladder or rectum. (from AJCC 7th Ed.)
Clinical N StageUterine Adenosarcoma American Joint Committee on Cancer (AJCC) Edition 7 Clinical Regional Lymph Node N Stage34473061.0CHARACTER
NXAdenosarcoma pNX TNM Finding v7Regional lymph nodes cannot be assessed. (from AJCC 7th Ed.)
N0Adenosarcoma pN0 TNM Finding v7No regional lymph node metastasis. (from AJCC 7th Ed.)
N1Adenosarcoma pN1 TNM Finding v7Regional lymph node metastasis. (from AJCC 7th Ed.)
Clinical M StageUterine Adenosarcoma American Joint Committee on Cancer (AJCC) Edition 7 Clinical Distant Metastasis M Stage34473081.0CHARACTER
M0Adenosarcoma cM0 TNM Finding v7No distant metastasis. (from AJCC 7th Ed.)
M1Adenosarcoma cM1 TNM Finding v7Distant metastasis (excluding adnexa, pelvic and abdominal tissues). (from AJCC 7th Ed.)
Pathologic T StageUterine Adenosarcoma American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Tumor T Stage34473051.0CHARACTER
TXAdenosarcoma pTX TNM Finding v7Primary tumor cannot be assessed. (from AJCC 7th Ed.)
T0Adenosarcoma pT0 TNM Finding v7No evidence of primary tumor. (from AJCC 7th Ed.)
T1Adenosarcoma pT1 TNM Finding v7Tumor limited to the uterus. (from AJCC 7th Ed.)
T1aAdenosarcoma pT1a TNM Finding v7Tumor limited to endometrium/endocervix. (from AJCC 7th Ed.)
T1bAdenosarcoma pT1b TNM Finding v7Tumor invades to less than half of the myometrium. (from AJCC 7th Ed.)
T1cAdenosarcoma pT1c TNM Finding v7Tumor invades more than half of the myometrium. (from AJCC 7th Ed.)
T2Adenosarcoma pT2 TNM Finding v7Tumor extends beyond the uterus, within the pelvis. (from AJCC 7th Ed.)
T2aAdenosarcoma pT2a TNM Finding v7Tumor involves adnexa. (from AJCC 7th Ed.)
T2bAdenosarcoma pT2b TNM Finding v7Tumor involves other pelvic tissues. (from AJCC 7th Ed.)
T3Adenosarcoma pT3 TNM Finding v7Tumor involves abdominal tissues. (from AJCC 7th Ed.)
T3aAdenosarcoma pT3a TNM Finding v7Tumor involves abdominal tissues, one site. (from AJCC 7th Ed.)
T3bAdenosarcoma pT3b TNM Finding v7Tumor invades abdominal tissues, more than one site. (from AJCC 7th Ed.)
T4Adenosarcoma pT4 TNM Finding v7Tumor invades bladder or rectum. (from AJCC 7th Ed.)
Pathologic N StageUterine Adenosarcoma American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Regional Lymph Node N Stage34473071.0CHARACTER
NXAdenosarcoma pNX TNM Finding v7Regional lymph nodes cannot be assessed. (from AJCC 7th Ed.)
N0Adenosarcoma pN0 TNM Finding v7No regional lymph node metastasis. (from AJCC 7th Ed.)
N1Adenosarcoma pN1 TNM Finding v7Regional lymph node metastasis. (from AJCC 7th Ed.)
Pathologic M StageUterine Adenosarcoma American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Distant Metastasis M Stage34473091.0CHARACTER
M1Adenosarcoma pM1 TNM Finding v7Distant metastasis (excluding adnexa, pelvic and abdominal tissues). (from AJCC 7th Ed.)
Disease StageUterine Adenosarcoma American Joint Committee on Cancer (AJCC) Edition 7 Group Stage34473101.0CHARACTER
IStage I Uterine SarcomaStage I includes: T1, N0, M0. T1: Tumor limited to the uterus. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)
IAStage IA Uterine SarcomaStage IA includes: T1a, N0, M0. T1a: For leiomyosarcoma and endometrial stromal sarcoma: tumor 5 cm or less in greatest dimension. For adenosarcoma: tumor limited to endometrium/endocervix. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)
IBStage IB Uterine SarcomaStage IB includes: T1b, N0, M0. T1b: For leiomyosarcoma and endometrial stromal sarcoma: tumor more than 5 cm in greatest dimension. For adenosarcoma: tumor invades to less than half of the myometrium. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)
ICStage IC Uterine SarcomaStage IC includes: T1c, N0, M0. T1c: For adenosarcoma: tumor invades more than half of the myometrium. N0: No regional lymph node metastasis. M0: No distant metastasis. Stage IC does not apply for leiomyosarcoma and endometrial stromal sarcoma. (AJCC 7th ed.)
IIStage II Uterine SarcomaStage II includes: T2, N0, M0. T2: Tumor extends beyond the uterus, within the pelvis. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)
IIIAStage IIIA Uterine SarcomaStage IIIA includes: T3a, N0, M0. T3a: Tumor infiltrates abdominal tissues, one side. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)
IIIBStage IIIB Uterine SarcomaStage IIIB includes: T3b, N0, M0. T3b: Tumor infiltrates abdominal tissues, more than one side. N0: No regional lymph node metastasis. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)
IIICStage IIIC Uterine SarcomaStage IIIC includes: T1-T3, N1, M0. T1: Tumor limited to the uterus. T2: Tumor extends beyond the uterus, within the pelvis. T3: Tumor infiltrates abdominal tissues. N1: Regional lymph node metastasis. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)
IVAStage IVA Uterine SarcomaStage IVA includes: T4, Any N, M0. T4: Tumor involves bladder or rectum. M0: No distant metastasis. This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)
IVBStage IVB Uterine SarcomaStage IVB includes: Any T, Any N, M1. M1: Distal metastasis (excluding adnexa, pelvic and abdominal tissues). This staging applies to leiomyosarcoma, endometrial stromal sarcoma, and adenosarcoma. (AJCC 7th ed.)
Stage unknownStage UnknownA finding indicating that the extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.
FIGO StageGynecologic Uterine Sarcoma Tumor Federation of Gynecology and Obstetrics Gynecologic (FIGO) 2009 Stage34749881.0CHARACTER
IAdenosarcoma pT1 TNM Finding v7Tumor limited to the uterus. (from AJCC 7th Ed.)
IAAdenosarcoma pT1a TNM Finding v7Tumor limited to endometrium/endocervix. (from AJCC 7th Ed.)
IBAdenosarcoma pT1b TNM Finding v7Tumor invades to less than half of the myometrium. (from AJCC 7th Ed.)
ICAdenosarcoma pT1c TNM Finding v7Tumor invades more than half of the myometrium. (from AJCC 7th Ed.)
IIAdenosarcoma pT2 TNM Finding v7Tumor extends beyond the uterus, within the pelvis. (from AJCC 7th Ed.)
IIAAdenosarcoma pT2a TNM Finding v7Tumor involves adnexa. (from AJCC 7th Ed.)
IIBAdenosarcoma pT2b TNM Finding v7Tumor involves other pelvic tissues. (from AJCC 7th Ed.)
IIIAdenosarcoma pT3 TNM Finding v7Tumor involves abdominal tissues. (from AJCC 7th Ed.)
IIIAAdenosarcoma pT3a TNM Finding v7Tumor involves abdominal tissues, one site. (from AJCC 7th Ed.)
IIICAdenosarcoma pT3b TNM Finding v7Tumor invades abdominal tissues, more than one site. (from AJCC 7th Ed.)
IVAdenosarcoma pT4 TNM Finding v7Tumor invades bladder or rectum. (from AJCC 7th Ed.)
Optional Corpus Uteri Sarcoma Staging QuestionsThere is no requirement for inclusion of these elements on the case report form. If the design and scientific questions posed in the study dictate the need to collect this type of data, these elements should be included.
Staging Time PointDisease Staging Timepoint Name28473521.0CHARACTER
Current DiagnosisCurrent DiagnosisOccurring in or belonging to the present time.: The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.
Initial DiagnosisFirst DiagnosisPreceding all others in time or space or degree.: The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.
RestagingRestagingRepeat of staging assessment
Study EnrollmentClinical Study EnrollmentResearch conducted with human subjects or on material of human origin in which an investigator directly interacts with human subjects; includes development of new technologies, mechanism of human diseases, therapy, clinical trials, epidemiology, behavior and health services research. : Enrollment; to insert, register, or enter in a list, catalog, or roll. (Merriam-Webster Online)